Índice

• • ·Editorial board

    Página :i

    

• Editorial

  • ·Using the respective contributions of postprandial and basal glucose for tailoring treatments in type 2 diabetes

    Página :179-182

    L. Monnier, C. Colette

    Resumen Resumen Esquema Esquema  

• Reviews

  • ·Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control

    Página :183-194

    A.J. Scheen, N. Esser, N. Paquot

    Resumen Resumen Esquema Esquema  
  • ·Is HbA_1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?

    Página :195-201

    T. Bejan-Angoulvant, C. Cornu, P. Archambault, B. Tudrej, P. Audier, Y. Brabant, F. Gueyffier, R. Boussageon

    Resumen Resumen Esquema Esquema  

• Original articles

  • ·Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: A double-blind placebo-controlled randomized trial

    Página :202-207

    F. Guerrero-Romero, L.E. Simental-Mendía, G. Hernández-Ronquillo, M. Rodriguez-Morán

    Resumen Resumen Esquema Esquema  
  • ·Comparing kidney outcomes in type 2 diabetes treated with different sulphonylureas in real-life clinical practice

    Página :208-215

    Y.-h. Lee, C.J. Lee, H.S. Lee, E.Y. Choe, B.-W. Lee, C.W. Ahn, B.-S. Cha, H.C. Lee, B. Balkau, E.S. Kang

    Resumen Resumen Esquema Esquema   
  • ·Individualizing treatment of type 2 diabetes by targeting postprandial or fasting hyperglycaemia: Response to a basal vs a premixed insulin regimen by HbA_1c quartiles and ethnicity

    Página :216-222

    A.J. Scheen, H. Schmitt, H.H. Jiang, T. Ivanyi

    Resumen Resumen Esquema Esquema  
  • ·Similar glucose control with basal–bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification

    Página :223-230

    R. Malek, F. Ajili, S.H. Assaad-Khalil, A. Shinde, J.W. Chen, E. Van den Berg

    Resumen Resumen Esquema Esquema  
  • ·Treatment maintenance duration of dual therapy with metformin and sitagliptin in type 2 diabetes: The ODYSSEE observational study

    Página :231-238

    P. Valensi, G. de Pouvourville, N. Benard, C. Chanut-Vogel, C. Kempf, E. Eymard, C. Moisan, J. Dallongeville

    Resumen Resumen Esquema Esquema   
  • ·Screening for dysglycaemia during pregnancy: Proposals conciliating International Association of Diabetes and Pregnancy Study Group (IADPSG) and US National Institutes of Health (NIH) panels

    Página :239-243

    E. Cosson, P. Valensi, L. Carbillon

    Resumen Resumen Esquema Esquema   

• Short reports

  • ·Efficacy of vildagliptin and sitagliptin in lowering fasting plasma glucose: Results of a randomized controlled trial

    Página :244-247

    R. Göke, P. Eschenbach, E.D. Dütting

    Resumen Resumen Esquema Esquema  
  • ·Increased TSH in obesity: Evidence for a BMI-independent association with leptin

    Página :248-251

    C. Bétry, M.A. Challan-Belval, A. Bernard, A. Charrié, J. Drai, M. Laville, C. Thivolet, E. Disse

    Resumen Resumen Esquema Esquema
  • ·Liraglutide in whole-pancreas transplant patients with impaired glucose homoeostasis: A case series

    Página :252-257

    B. Cariou, C. Bernard, D. Cantarovich

    Resumen Resumen Esquema Esquema

• Letters to the editor

  • ·Malignant insulinoma may arise during the course of type 1 diabetes mellitus: A case report

    Página :258-261

    S. Lablanche, M. Chobert-Bakouline, O. Risse, M.-H. Laverrière, O. Chabre, P.-Y. Benhamou

    Resumen Resumen Esquema Esquema  
  • ·Different associations of body mass index and visceral fat area with metabolic parameters and adipokines in Japanese patients with type 2 diabetes

    Página :261-262

    H. Yanai, Y. Hirowatari

    Resumen Resumen Esquema Esquema